These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7689270)

  • 1. Renal transplantation under FK 506 in African-Americans: early experience.
    McCauley J; Shapiro R; Woods H; Scantlebury V; Irish W; McMichael J; Jordan M; Vivas C; Starzl TE
    Transplant Proc; 1993 Aug; 25(4):2468-9. PubMed ID: 7689270
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of race and immunosuppression in renal transplantation: three-year survival results from a US multicenter, randomized trial. FK506 Kidney Transplant Study Group.
    Neylan JF
    Transplant Proc; 1998 Jun; 30(4):1355-8. PubMed ID: 9636551
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression.
    Odocha O; McCauley J; Scantlebury V; Shapiro R; Carroll P; Jordan M; Vivas C; Fung JJ; Starzl TE
    Transplant Proc; 1993 Aug; 25(4):2435. PubMed ID: 7689269
    [No Abstract]   [Full Text] [Related]  

  • 4. Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group.
    Neylan JF
    Transplantation; 1998 Feb; 65(4):515-23. PubMed ID: 9500626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New immunosuppression strategies are needed to improve kidney allograft survival in blacks.
    Tesi RJ; Dagoglou P; Zarifian A; Etheredge EE
    Transplant Proc; 1996 Aug; 28(4):2125-7. PubMed ID: 8769176
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years.
    Ahsan N; Johnson C; Gonwa T; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; VanVeldhuisen P; Salm K; Tolzman D; Fitzsimmons WE
    Transplantation; 2001 Jul; 72(2):245-50. PubMed ID: 11477347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive effects of FK 506 on rat renal allograft survival, in comparison with cyclosporine.
    Jiang H; Fujitsu T; Sakuma S; Ogawa T; Tamura K; Fujii Y; Akiyama Y; Izumi S; Takahara S; Ishibashi M
    Transplant Proc; 1995 Feb; 27(1):367-9. PubMed ID: 7533413
    [No Abstract]   [Full Text] [Related]  

  • 8. Outcomes in African American kidney transplant patients receiving tacrolimus and mycophenolic acid immunosuppression.
    Narayanan M; Pankewycz O; El-Ghoroury M; Shihab F; Wiland A; McCague K; Chan L
    Transplantation; 2013 Feb; 95(4):566-72. PubMed ID: 23423268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of kidney transplantation in African-Americans using tacrolimus.
    Scantlebury VP; Shapiro R; Irish W; Jordan ML; Vivas C; Gritsch HA; Fung JJ; McCauley J; Simmons RL; Starzl TE
    Transplant Proc; 1997 Dec; 29(8):3731-2. PubMed ID: 9414906
    [No Abstract]   [Full Text] [Related]  

  • 10. Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression.
    Odocha O; McCauley J; Scantlebury V; Shapiro R; Carroll P; Jordan M; Vivas C; Fung JJ; Starzl TE
    Transplant Proc; 1993 Aug; 25(4):2433-4. PubMed ID: 7689268
    [No Abstract]   [Full Text] [Related]  

  • 11. FK 506 versus cyclosporine in pediatric liver transplantation.
    Tzakis AG; Reyes J; Todo S; Green M; Ohya T; Jain A; Abu-Elmagd K; Alessiani M; Fung JJ; Starzl TE
    Transplant Proc; 1991 Dec; 23(6):3010-5. PubMed ID: 1721343
    [No Abstract]   [Full Text] [Related]  

  • 12. FK 506 conversion of renal allografts failing cyclosporine immunosuppression.
    Jordan ML; Shapiro R; Jensen CW; Scantlebury V; Fung J; Tzakis A; McCauley J; Jain A; Demetrius J; Randhawa P
    Transplant Proc; 1991 Dec; 23(6):3078-81. PubMed ID: 1721365
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of acute renal transplant rejection with FK 506 in patients on cyclosporine after failure of standard antirejection therapy.
    Scott-Douglas N; Zimmerman D; Klassen J
    Transplant Proc; 1996 Dec; 28(6):3165. PubMed ID: 8962226
    [No Abstract]   [Full Text] [Related]  

  • 14. Conversion from cyclosporine to tacrolimus in renal allograft recipients with chronic graft nephropathy: preliminary report.
    Morris-Stiff G; Baboolal K; Singh J; Balaji V; Ostrowski K; Moore R; Lord R; Jurewicz A
    Transplant Proc; 1998 Jun; 30(4):1245-6. PubMed ID: 9636506
    [No Abstract]   [Full Text] [Related]  

  • 15. FK 506 salvage of renal allografts with ongoing rejection failing cyclosporine immunosuppression.
    Jordan ML; Shapiro R; Vivas CA; Scantlebury VP; Darras FS; Carrieri G; McCauley J; Demetris AJ; Randhawa P; Jensen C
    Transplant Proc; 1993 Feb; 25(1 Pt 1):638-40. PubMed ID: 7679827
    [No Abstract]   [Full Text] [Related]  

  • 16. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.
    Ichikura H; Tanabe K; Tokumoto T; Shimuzu T; Ishikawa N; Harano M; Inui M; Manu M; Ito S; Shimmura H; Okuda H; Yagisawa T; Fuchinoue S; Toma H
    Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911
    [No Abstract]   [Full Text] [Related]  

  • 17. Decreased rejection episodes in African-American renal transplant recipients receiving mycophenolate mofetil/tacrolimus therapy.
    Weber M; Deng S; Arenas J; Aradhye S; Grossman R; Shaw L; Naji A; Barker C; Brayman KL
    Transplant Proc; 1997 Dec; 29(8):3669-70. PubMed ID: 9414883
    [No Abstract]   [Full Text] [Related]  

  • 18. Japanese multicenter studies of FK 506 in renal transplantation. Japanese FK 506 Study Group.
    Ochiai T; Ishibashi M; Fukao K; Takahashi K; Endo T; Yokoyama I; Uchida K; Ohshima S; Takahara S; Morozumi K
    Transplant Proc; 1995 Feb; 27(1):50-3. PubMed ID: 7533419
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine.
    Fung J; Abu-Elmagd K; Jain A; Gordon R; Tzakis A; Todo S; Takaya S; Alessiani M; Demetris A; Bronster O
    Transplant Proc; 1991 Dec; 23(6):2977-83. PubMed ID: 1721333
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of race on delayed renal allograft function and outcome in the cyclosporine era.
    Cacciarelli TV; Sumrani N; DiBenedetto A; Hong JH; Sommer BG
    Transplant Proc; 1993 Aug; 25(4):2460-1. PubMed ID: 8356633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.